NAXEPRY
Live / Allowed — Second extension granted (statement of use) (as of 28 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98757382
- Mark type
- Word mark
- Filed
- 18 Sept 2024
- Published for opposition
- 22 Apr 2025
- Attorney of record
- Bethany J. Whelan
Goods and services
- Class 005 — Pharmaceuticals: Nasal spray preparations; nasal sprays for medical purposes; nasal spray preparations for use in treating Type 1 anaphylaxis reactions; pharmaceutical formulations for use in treating Type 1 anaphylaxis reactions
- Class 016 — Paper goods and printed matter: Printed matter, namely, brochures, leaflets, and manuals in the field of pharmaceuticals, pharmaceutical research, and healthcare
- Class 044 — Medical, beauty and agricultural services: Providing a website featuring medical information; providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals
Owner
- AMPHASTAR PHARMACEUTICALS, INC., Rancho Cucamonga, CA, US
- AMPHASTAR PHARMACEUTICALS, INC., Rancho Cucamonga, CA, US
Prosecution history
- 28 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2026 — SOU EXTENSION 2 GRANTED
- 28 May 2026 — SOU EXTENSION 2 FILED
- 28 May 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2025 — SOU EXTENSION 1 GRANTED
- 11 Jul 2025 — SOU EXTENSION 1 FILED
- 11 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2025 — PUBLISHED FOR OPPOSITION
- 16 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Mar 2025 — ASSIGNED TO EXAMINER
- 25 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED